NCT07633171Recruiting
Multimodal Glucose Prediction in Type 2 Diabetes
CGM- and Behavior-based Large Health Model for Just-in-time Diabetes Management
Source: ClinicalTrials.gov · Last updated 8 Oct 2026
Brief summary (registry, in English)
The primary objective of this research, funded by Samsung Strategic Alliance for Research and Technology, is to develop multi-modal foundation models that integrate Continuous Glucose Monitoring (CGM) data with patient behavior data (food intake, medication, and physical activity) to improve real-time glucose prediction and personalized diabetes management for patients with Type 2 diabetes (T2D), delivered via mobile apps and digital health tools.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 36 (estimated)
- First submitted
- 2 Jun 2026
- Start date
- 7 Oct 2026
- Primary completion date
- 15 Jan 2027
- Lead sponsor
- Johns Hopkins University
- Diseases
- Type 2 diabetes
- NCT number
- NCT07633171
What you commit to
- Study type: Observational
- Planned participants: 36
- From 7 Oct 2026 to the primary completion date, 15 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- CGM time-below-range \> 4% (i.e. hypoglycemia) in the 14 days prior to enrollment.
- Hospitalization for Diabetic Ketoacidosis (DKA) or severe hypoglycemic episode within the previous 6 months.
Other illness
- Has hearing or vision impairment
- Diagnosed with other forms of diabetes (e.g. Type 1 Diabetes, Latent Autoimmune Diabetes in Adults (LADA), Maturity-Onset Diabetes of the Young (MODY), or Gestational diabetes)
Other
- Pregnant
- Non-English speaker
- Use of an insulin pump (i.e. automated insulin delivery system)
- Non-Android smartphone user (i.e., Apple iOS)
Who the study is looking for
- 18-75 years old
- Registered patient under Johns Hopkins Medicine (JHM)
- Type 2 Diabetes diagnosis
- Diabetes managed by a primary care physician or endocrinologist at JHM
- Android Smartphone user
- Must have a Dexcom G7 or FreeStyle Libre 3 CGM and using a mobile app to access their CGM data (G7 or Libre 3 apps)
- 2 weeks of usage (with at least 50% wear time) prior to study participation required
- CGM Time in Range of \<70% in 14 days prior to enrollment
- Must be able to read, understand, and communicate in English
- Must not have hearing or vision impairments
- Willingness to Download the Welldoc app
- Agree to wear a SAMSUNG Galaxy Watch at least 12 hours per day
- Download SAMSUNG Health (Non-SAMSUNG Phone user)
- Download Google Health Connect
- Use CGM at least 80% of the time
- Take a photo of all meals
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Johns Hopkins Medicine Coordinator of this site? Confirm its status | Baltimore | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.